Teva to buy U.S. drug developer Auspex Pharma for $3.5 bln

March 30 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd said it would buy U.S. drug developer Auspex Pharmaceuticals Inc for $3.5 billion to boost its portfolio of treatments for the central...